Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
4 %
$ 358 M
Market Cap
-7.43
P/E
CMPX - LONG-TERM DEBT
Long-term Debt CMPX - Compass Therapeutics, Inc.
536 K
LAST VALUE
-58.07%
2 YEAR CAGR
-45.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR